Shuangyang Zhang
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients.
Journal: Schizophrenia (Heidelberg, Germany)
Published: December 21, 2023
Effect of Probiotic Supplements on Oxidative Stress Biomarkers in First-Episode Bipolar Disorder Patients: A Randomized, Placebo-Controlled Trial.
Journal: Frontiers in pharmacology
Published: December 06, 2021
Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.
Journal: European archives of psychiatry and clinical neuroscience
Published: October 30, 2021
Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling.
Journal: Frontiers in endocrinology
Published: June 18, 2021
Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders.
Journal: Frontiers in pharmacology
Published: February 15, 2021
A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits.
Journal: Frontiers in pharmacology
Published: September 30, 2020
Prognostic value of liver and kidney function parameters and their correlation with the ratio of urine-to-plasma paraquat in patients with paraquat poisoning.
Journal: Basic & clinical pharmacology & toxicology
Published: August 21, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026